- Home
- NN vs FTRE Comparison
NN vs FTRE Comparison
Compare NN & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NN | FTRE |
|---|---|---|
| Founded | 2007 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 1.9B |
| IPO Year | 2021 | 2023 |
Fundamental Metrics
Financial Performance| Metric | NN | FTRE |
|---|---|---|
| Price | $11.49 | $21.06 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 13 |
| Target Price | ★ $33.67 | $22.63 |
| AVG Volume (30 Days) | ★ 3.7M | 1.9M |
| Earning Date | 11-10-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $4,573,000.00 | ★ $2,723,400,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.11 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1.00 |
| 52 Week Low | $8.98 | $8.55 |
| 52 Week High | $24.42 | $26.16 |
Technical Indicators
Market Signals| Indicator | NN | FTRE |
|---|---|---|
| Relative Strength Index (RSI) | 44.75 | 45.85 |
| Support Level | $8.98 | $16.34 |
| Resistance Level | $17.65 | $21.25 |
| Average True Range (ATR) | 0.97 | 1.36 |
| MACD | 0.31 | -0.11 |
| Stochastic Oscillator | 57.37 | 15.57 |
Price Performance
Historical ComparisonAbout NN NextNav Inc.
NextNav Inc provides GPS service. The company NextNav TerraPoiNT system delivers resilient, next-generation, complementary positioning, navigation, and timing (PNT) solutions designed to overcome the limitations and vulnerabilities of existing space-based Global Navigation Satellite Systems (GNSS), including the Global Positioning System (GPS). The products of the company include NextNav Pinnacle: Accurate vertical location, NextNav 3D: 3D location visualization, NextNav TerraPoiNT: Resilient PNT for 3D and indoor geolocation, Next Generation Solution: Terrestrial 3D PNT powered by spectrum.
About FTRE Fortrea Holdings Inc.
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.